Company Filing History:
Years Active: 2010-2016
Title: Marc Riemenschnitter: Innovator in Pharmaceutical Compositions
Introduction
Marc Riemenschnitter is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 4 patents to his name, Riemenschnitter's work focuses on enhancing the efficacy and delivery of therapeutic agents.
Latest Patents
Among his latest patents, Riemenschnitter has developed an extended-release composition comprising a somatostatin derivative in microparticles. This invention relates to improved microparticles that contain a somatostatin analog, along with a process for making these microparticles and pharmaceutical compositions that include them. Another significant patent involves microparticles comprising somatostatin analogues, which are embedded in a biocompatible pharmacologically acceptable polymer matrix for long-acting release, along with pharmaceutical compositions that utilize such microparticles.
Career Highlights
Throughout his career, Riemenschnitter has worked with prominent companies in the pharmaceutical industry, including Novartis AG and LTS Lohmann Therapie-Systeme AG. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.
Collaborations
Riemenschnitter has collaborated with several professionals in his field, including Olivier Lambert and Markus Ahlheim. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Marc Riemenschnitter's innovative work in pharmaceutical compositions showcases his commitment to improving drug delivery systems. His contributions have the potential to significantly impact the effectiveness of treatments in the medical field.